Report Detail
COVID-19 Impact on Global Peptide APIs Market Insights, Forecast to 2026
- RnM4064119 |
- 16 June, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Peptide APIs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide APIs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Peptide APIs market is segmented into
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Segment by Application, the Peptide APIs market is segmented into
Cancer
Diabetes
Obesity
Fertility
Other
Regional and Country-level Analysis
The Peptide APIs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptide APIs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Peptide APIs Market Share Analysis
Peptide APIs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Peptide APIs business, the date to enter into the Peptide APIs market, Peptide APIs product introduction, recent developments, etc.
The major vendors covered:
CordenPharma
PolyPeptide
Bachem
AmbioPharm
Pepscan
BCN Peptides
Senn Chemicals
...
1 Study Coverage
- 1.1 Peptide APIs Product Introduction
- 1.2 Market Segments
- 1.3 Key Peptide APIs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Peptide APIs Market Size Growth Rate by Type
- 1.4.2 Liquid Phase Peptide Synthesis (LPPS)
- 1.4.3 Solid Phase Peptide Synthesis (SPPS)
- 1.5 Market by Application
- 1.5.1 Global Peptide APIs Market Size Growth Rate by Application
- 1.5.2 Cancer
- 1.5.3 Diabetes
- 1.5.4 Obesity
- 1.5.5 Fertility
- 1.5.6 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Peptide APIs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Peptide APIs Industry
- 1.6.1.1 Peptide APIs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Peptide APIs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Peptide APIs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Peptide APIs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Peptide APIs Market Size Estimates and Forecasts
- 2.1.1 Global Peptide APIs Revenue 2015-2026
- 2.1.2 Global Peptide APIs Sales 2015-2026
- 2.2 Peptide APIs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Peptide APIs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Peptide APIs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Peptide APIs Competitor Landscape by Players
- 3.1 Peptide APIs Sales by Manufacturers
- 3.1.1 Peptide APIs Sales by Manufacturers (2015-2020)
- 3.1.2 Peptide APIs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Peptide APIs Revenue by Manufacturers
- 3.2.1 Peptide APIs Revenue by Manufacturers (2015-2020)
- 3.2.2 Peptide APIs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Peptide APIs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Peptide APIs Revenue in 2019
- 3.2.5 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Peptide APIs Price by Manufacturers
- 3.4 Peptide APIs Manufacturing Base Distribution, Product Types
- 3.4.1 Peptide APIs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Peptide APIs Product Type
- 3.4.3 Date of International Manufacturers Enter into Peptide APIs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Peptide APIs Market Size by Type (2015-2020)
- 4.1.1 Global Peptide APIs Sales by Type (2015-2020)
- 4.1.2 Global Peptide APIs Revenue by Type (2015-2020)
- 4.1.3 Peptide APIs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Peptide APIs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Peptide APIs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Peptide APIs Revenue Forecast by Type (2021-2026)
- 4.2.3 Peptide APIs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Peptide APIs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Peptide APIs Market Size by Application (2015-2020)
- 5.1.1 Global Peptide APIs Sales by Application (2015-2020)
- 5.1.2 Global Peptide APIs Revenue by Application (2015-2020)
- 5.1.3 Peptide APIs Price by Application (2015-2020)
- 5.2 Peptide APIs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Peptide APIs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Peptide APIs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Peptide APIs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Peptide APIs by Country
- 6.1.1 North America Peptide APIs Sales by Country
- 6.1.2 North America Peptide APIs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Peptide APIs Market Facts & Figures by Type
- 6.3 North America Peptide APIs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Peptide APIs by Country
- 7.1.1 Europe Peptide APIs Sales by Country
- 7.1.2 Europe Peptide APIs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Peptide APIs Market Facts & Figures by Type
- 7.3 Europe Peptide APIs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Peptide APIs by Region
- 8.1.1 Asia Pacific Peptide APIs Sales by Region
- 8.1.2 Asia Pacific Peptide APIs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Peptide APIs Market Facts & Figures by Type
- 8.3 Asia Pacific Peptide APIs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Peptide APIs by Country
- 9.1.1 Latin America Peptide APIs Sales by Country
- 9.1.2 Latin America Peptide APIs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Peptide APIs Market Facts & Figures by Type
- 9.3 Central & South America Peptide APIs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Peptide APIs by Country
- 10.1.1 Middle East and Africa Peptide APIs Sales by Country
- 10.1.2 Middle East and Africa Peptide APIs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Peptide APIs Market Facts & Figures by Type
- 10.3 Middle East and Africa Peptide APIs Market Facts & Figures by Application
11 Company Profiles
- 11.1 CordenPharma
- 11.1.1 CordenPharma Corporation Information
- 11.1.2 CordenPharma Description, Business Overview and Total Revenue
- 11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CordenPharma Peptide APIs Products Offered
- 11.1.5 CordenPharma Recent Development
- 11.2 PolyPeptide
- 11.2.1 PolyPeptide Corporation Information
- 11.2.2 PolyPeptide Description, Business Overview and Total Revenue
- 11.2.3 PolyPeptide Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 PolyPeptide Peptide APIs Products Offered
- 11.2.5 PolyPeptide Recent Development
- 11.3 Bachem
- 11.3.1 Bachem Corporation Information
- 11.3.2 Bachem Description, Business Overview and Total Revenue
- 11.3.3 Bachem Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bachem Peptide APIs Products Offered
- 11.3.5 Bachem Recent Development
- 11.4 AmbioPharm
- 11.4.1 AmbioPharm Corporation Information
- 11.4.2 AmbioPharm Description, Business Overview and Total Revenue
- 11.4.3 AmbioPharm Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 AmbioPharm Peptide APIs Products Offered
- 11.4.5 AmbioPharm Recent Development
- 11.5 Pepscan
- 11.5.1 Pepscan Corporation Information
- 11.5.2 Pepscan Description, Business Overview and Total Revenue
- 11.5.3 Pepscan Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pepscan Peptide APIs Products Offered
- 11.5.5 Pepscan Recent Development
- 11.6 BCN Peptides
- 11.6.1 BCN Peptides Corporation Information
- 11.6.2 BCN Peptides Description, Business Overview and Total Revenue
- 11.6.3 BCN Peptides Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 BCN Peptides Peptide APIs Products Offered
- 11.6.5 BCN Peptides Recent Development
- 11.7 Senn Chemicals
- 11.7.1 Senn Chemicals Corporation Information
- 11.7.2 Senn Chemicals Description, Business Overview and Total Revenue
- 11.7.3 Senn Chemicals Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Senn Chemicals Peptide APIs Products Offered
- 11.7.5 Senn Chemicals Recent Development
- 11.1 CordenPharma
- 11.1.1 CordenPharma Corporation Information
- 11.1.2 CordenPharma Description, Business Overview and Total Revenue
- 11.1.3 CordenPharma Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CordenPharma Peptide APIs Products Offered
- 11.1.5 CordenPharma Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Peptide APIs Market Estimates and Projections by Region
- 12.1.1 Global Peptide APIs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Peptide APIs Revenue Forecast by Regions 2021-2026
- 12.2 North America Peptide APIs Market Size Forecast (2021-2026)
- 12.2.1 North America: Peptide APIs Sales Forecast (2021-2026)
- 12.2.2 North America: Peptide APIs Revenue Forecast (2021-2026)
- 12.2.3 North America: Peptide APIs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Peptide APIs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Peptide APIs Sales Forecast (2021-2026)
- 12.3.2 Europe: Peptide APIs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Peptide APIs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Peptide APIs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Peptide APIs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Peptide APIs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Peptide APIs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Peptide APIs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Peptide APIs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Peptide APIs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Peptide APIs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Peptide APIs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Peptide APIs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Peptide APIs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Peptide APIs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Peptide APIs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Peptide APIs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Peptide APIs. Industry analysis & Market Report on COVID-19 Impact on Global Peptide APIs is a syndicated market report, published as COVID-19 Impact on Global Peptide APIs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Peptide APIs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
